Cargando…
Engineered MED12 mutations drive uterine fibroid-like transcriptional and metabolic programs by altering the 3D genome compartmentalization
Uterine fibroid (UF) tumors originate from a mutated smooth muscle cell (SMC). Nearly 70% of these tumors are driven by hotspot recurrent somatic mutations in the MED12 gene; however, there are no tractable genetic models to study the biology of UF tumors because, under culture conditions, the non-m...
Autores principales: | Buyukcelebi, Kadir, Chen, Xintong, Abdula, Fatih, Duval, Alexander, Ozturk, Harun, Seker-Polat, Fidan, Jin, Qiushi, Yin, Ping, Feng, Yue, Wei, Jian-Jun, Bulun, Serdar, Yue, Feng, Adli, Mazhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934745/ https://www.ncbi.nlm.nih.gov/pubmed/36798375 http://dx.doi.org/10.21203/rs.3.rs-2537075/v1 |
Ejemplares similares
-
Engineered MED12 mutations drive leiomyoma-like transcriptional and metabolic programs by altering the 3D genome compartmentalization
por: Buyukcelebi, Kadir, et al.
Publicado: (2023) -
Adenomyosis pathogenesis: insights from next-generation sequencing
por: Bulun, Serdar E, et al.
Publicado: (2021) -
Midlife Urinary Phthalate Metabolite Concentrations and Prior Uterine Fibroid Diagnosis
por: Pacyga, Diana C., et al.
Publicado: (2022) -
Tryptophan 2,3-Dioxygenase-2 in Uterine Leiomyoma: Dysregulation by MED12 Mutation Status
por: Hutchinson, Anne P., et al.
Publicado: (2022) -
Aberrant R-loop-induced replication stress in MED12-mutant uterine fibroids
por: Muralimanoharan, Sribalasubashini, et al.
Publicado: (2022)